ALLMedicine™ Hypoglycemia Center
Research & Reviews 7,320 results
https://doi.org/10.1080/14656566.2022.2113385
Expert Opinion on Pharmacotherapy; Koufakis T, Doumas M et. al.
Aug 14th, 2022 - According to their selectivity for sodium-glucose cotransporters (SGLT) 1 and 2, gliflozins could be subdivided into two additional categories: pure SGLT2 inhibitors, which are highly selective for SGLT2, and dual SGLT1/2 inhibitors which, in addi...
https://doi.org/10.1080/17434440.2022.2113387
Expert Review of Medical Devices; Tătaru I, Dragostin OM et. al.
Aug 14th, 2022 - Diabetes mellitus, commonly known as just diabetes, is a group of metabolic disorders characterised by a high blood sugar level over a prolonged period of time. In order to maintain this blood glucose value in normal parameters, a careful monitori...
https://doi.org/10.1016/j.numecd.2022.06.003
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Buzzetti R, Fadini GP et. al.
Aug 13th, 2022 - Data on second generation basal insulin (2BI) in people with type 2 diabetes (T2D) generated by clinical trials still need confirmation in real-world clinical settings. This study aimed at assessing the comparative effectiveness of 2BI [Glargine 3...
https://doi.org/10.12788/jfp.0394
The Journal of Family Practice; Champlain JM
Aug 13th, 2022 - Over 25% of adults ≥65 years of age have type 2 diabetes (T2D). Individualization of care is important in older adults with T2D, with treatment targets and therapeutic approaches informed by patient-specific medical, psychosocial, functional, and ...
https://doi.org/10.3390/ijerph19159616
International Journal of Environmental Research and Publi... de Bruin R, van Dalen SL et. al.
Aug 13th, 2022 - Beta-blockers are often used during pregnancy to treat cardiovascular diseases. The described neonatal side effects of maternal beta-blocker use are hypoglycemia and bradycardia, but the evidence base for these is yet to be evaluated comprehensive...
Guidelines 16 results
https://doi.org/10.1001/jama.2021.11922
JAMA , Davidson KW et. al.
Aug 11th, 2021 - Gestational diabetes is diabetes that develops during pregnancy. Prevalence of gestational diabetes in the US has been estimated at 5.8% to 9.2%, based on traditional diagnostic criteria, although it may be higher if more inclusive criteria are us...
https://doi.org/10.1016/j.ajog.2021.07.023
American Journal of Obstetrics and Gynecology; , Reddy UM et. al.
Aug 8th, 2021 - The administration of antenatal corticosteroids has been widely adopted as the standard of care in the management of pregnancies at risk for preterm delivery before 37 weeks of gestation, with the primary goal of reducing neonatal morbidity. Howev...
https://doi.org/10.1210/clinem/dgaa543
The Journal of Clinical Endocrinology and Metabolism; Brar PC, Heksch R et. al.
Aug 19th, 2020 - The diagnosis of hypoglycemia and the use of diazoxide have risen in the last decade. Diazoxide is the only Food and Drug Agency-approved pharmacologic treatment for neonatal hypoglycemia caused by hyperinsulinism (HI). Recent publications have hi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855268
Journal of Inherited Metabolic Disease; Altassan R, Radenkovic S et. al.
Jul 19th, 2020 - Phosphoglucomutase 1 (PGM1) deficiency is a rare genetic disorder that affects glycogen metabolism, glycolysis, and protein glycosylation. Previously known as GSD XIV, it was recently reclassified as a congenital disorder of glycosylation, PGM1-CD...
https://doi.org/10.1016/j.jogc.2019.03.008
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Berger H, Gagnon R et. al.
Dec 2nd, 2019 - This guideline reviews the evidence relating to the diagnosis and obstetrical management of diabetes in pregnancy. The outcomes evaluated were short and long-term maternal outcomes including pre-eclampsia, Caesarean section, future diabetes and ot...
Drugs 241 results see all →
Clinicaltrials.gov 1,201 results
https://clinicaltrials.gov/ct2/show/NCT04790526
Aug 11th, 2022 - From the last three decades, the diabetes mellitus progress quadrupled.The International Diabetes Federation (IDF) approximate that 1 in 11 adults with age between 20 to 79 years have diabetes mellitus. Almost 90 percent of patients diagnosed with...
https://clinicaltrials.gov/ct2/show/NCT05319496
Aug 10th, 2022 - Objective: To evaluate the effectiveness of intermittently scanned continuous glucose monitoring (isCGM) with education and feedback on glycemic control at 12 weeks, in adults with type 2 diabetes and uncontrolled HbA1c (> 7.0%) not on insulin the...
https://clinicaltrials.gov/ct2/show/NCT05307237
Aug 10th, 2022 - There is strong evidence that poor glycemic control in the hospital is common. Given the known consequences of uncontrolled blood sugars during a hospitalization (e.g., infection, serious neurological and cardiac complications, mortality, longer l...
https://clinicaltrials.gov/ct2/show/NCT04430582
Aug 9th, 2022 - This study will test the hypothesis that recurrent hypoglycemia is associated with differences in cognition (thinking), by analyzing results of cognitive testing in individuals with a history of hypoglycemia as compared with those without known hy...
https://clinicaltrials.gov/ct2/show/NCT04786262
Aug 9th, 2022 - This study will evaluate the safety, tolerability and efficacy of VX-880 infusion in participants with Type 1 diabetes mellitus (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia.
News 1,577 results
https://www.medscape.com/viewarticle/977615
Aug 2nd, 2022 - This transcript has been edited for clarity. What an amazing time it is to be living with type 1 diabetes in 2022 and see the evolution of diabetes technology. I say this both personally and professionally. My brother was diagnosed with type 1 in ...
https://www.mdedge.com/migraine-challenge-center/article/256718/migraine/episodes-visual-disturbance
Aug 1st, 2022 - On the basis of the history, examination, and investigations, retinal migraine was diagnosed according to the International Classification of Headache Disorders, third edition (1. 2 migraine with aura; 1.
https://www.medscape.com/viewarticle/978399
Aug 1st, 2022 - Researchers published the study covered in this summary on researchsquare.com as a preprint that has not yet been peer reviewed. Key Takeaways In Japanese adults with type 1 diabetes insulin-pump treatment (continuous subcutaneous insulin infusion...
https://www.mdedge.com/type-2-diabetes-icymi/article/256649/diabetes/real-world-insights-initiating-or-switching-insulin
Jul 31st, 2022 - Key clinical point: In patients with type 2 diabetes (T2D), initiating or switching to insulin degludec/ aspart (IDegAsp) from other antidiabetic treatments was associated with improved glycemic control, lower basal insulin dose requirement in ins.
https://www.mdedge.com/type-2-diabetes-icymi/article/256290/diabetes/team-approach-managing-type-2-diabetes
Rozalina G. McCoy, MD, MS
Jul 25th, 2022 - Those of us who treat patients with type 2 diabetes (T2D) daily have long recognized a disturbing irony: diabetes is a disease whose management requires consistency in approach and constancy in delivery, but it is most prevalent among those whose.